drugset / Trial / NCT02843321
Combined Infusion of Cytotoxic T-Lymphocytes and Vaccination
NaSingle-groupOpen-labelTreatment
Summary
To assess the safety and biological efficacy of prophylactically administered donor-derived multi-infection specific cytotoxic T lymphocytes (CTLs) (targeting cytomegalovirus (CMV), Adenovirus (Adv), Epstein Barr virus (EBV), Varicella-Zoster virus (VZV), Influenza (Flu), BK virus (BKV), and Aspergillus (Asp)) combined with early immunisation with Influenza and VZV vaccines for the prevention of viral and fungal infection following allogeneic blood or marrow stem cell transplantation.
Timeline
- Start
- 2012-08
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donor derived infection-specific T-cells | Cell therapy | — | — |
| Subject | Fluvax | Vaccine | — | — |